ArticleFrontiers in medicine2021
Artificial Intelligence to Detect Meibomian Gland Dysfunction From
Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Artificial intelligence in ophthalmology: from innovation to clinical integration.Frontiers in ophthalmology · 2026Article
- Autoimmune Diseases of the Eyelid Skin: Molecular Pathways, Clinical Manifestations, and Therapeutic Insights.International journal of molecular sciences · 2025Review
- A Comprehensive Review Comparing Artificial Intelligence and Clinical Diagnostic Approaches for Dry Eye Disease.Diagnostics (Basel, Switzerland) · 2025Review
- Review
- In Vivo Confocal Microscopy for Automated Detection of Meibomian Gland Dysfunction: A Study Based on Deep Convolutional Neural Networks.Journal of imaging informatics in medicine · 2025Article
- Artificial Intelligence Applications in Ophthalmology.JMA journal · 2025Review
- Artificial intelligence in corneal diseases: A narrative review.Contact lens & anterior eye : the journal of the British Contact Lens Association · 2024Review
- Applications of Artificial Intelligence in Ophthalmology: Glaucoma, Cornea, and Oculoplastics.Cureus · 2024Review
- Artificial-Intelligence-Enhanced Analysis of In Vivo Confocal Microscopy in Corneal Diseases: A Review.Diagnostics (Basel, Switzerland) · 2024Review
- Potential applications of artificial intelligence in image analysis in cornea diseases: a review.Eye and vision (London, England) · 2024Review
- Prediction model of ocular metastasis from primary liver cancer: Machine learning-based development and interpretation study.Cancer medicine · 2023Article
- Artificial intelligence in ophthalmology: The path to the real-world clinic.Cell reports. Medicine · 2023Review
- Artificial intelligence-assisted diagnosis of ocular surface diseases.Frontiers in cell and developmental biology · 2023Review
- Impacts of gender and age on meibomian gland in aged people using artificial intelligence.Frontiers in cell and developmental biology · 2023Article
- Integration of Artificial Intelligence into the Approach for Diagnosis and Monitoring of Dry Eye Disease.Diagnostics (Basel, Switzerland) · 2022Review
- Accuracy and feasibility with AI-assisted OCT in retinal disorder community screening.Frontiers in cell and developmental biology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.